{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:51:58Z","timestamp":1761630718361},"reference-count":9,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.intimp.2015.02.038","type":"journal-article","created":{"date-parts":[[2015,3,9]],"date-time":"2015-03-09T23:45:46Z","timestamp":1425944746000},"page":"1-3","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Positive clinical outcome with IVIg as monotherapy in recurrent pemphigoid gestationis"],"prefix":"10.1016","volume":"26","author":[{"given":"Tegan","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esraa","family":"Alraqum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Razzaque Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2015.02.038_bb0005","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2340\/00015555-0209","article-title":"Persistent herpes gestationis treated with high-dose intravenous immunoglobulin","volume":"87","author":"Rodrigues","year":"2007","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.intimp.2015.02.038_bb0010","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1440-0960.2011.00854.x","article-title":"Successful treatment of a severe persistent case of pemphigoid gestationis with antepartum and postpartum intravenous immunoglobulin followed by azathioprine","volume":"53","author":"Gan","year":"2012","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.intimp.2015.02.038_bb0015","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2310\/7750.2009.09001","article-title":"Antepartum intravenous immunoglobulin therapy in refractory pemphigoid gestationis: case report and literature review","volume":"14","author":"Doiron","year":"2010","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.intimp.2015.02.038_bb0020","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1046\/j.1365-2230.1998.00342.x","article-title":"A severe persistent case of pemphigoid gestationis treated with intravenous immunoglobulins and cyclosporine","volume":"23","author":"Hern","year":"1998","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.intimp.2015.02.038_bb0025","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.jaad.2004.07.052","article-title":"Intravenous immunoglobulin in the treatment of persistent pemphigoid gestationis","volume":"51","author":"Kreuter","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.intimp.2015.02.038_bb0030","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.det.2011.03.002","article-title":"Pemphigoid gestationis: pathogenesis and clinical features","volume":"29","author":"Intong","year":"2011","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.intimp.2015.02.038_bb0035","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13023-014-0136-2","article-title":"Gestational pemphigoid","volume":"9","author":"Huilaja","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.intimp.2015.02.038_bb0040","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/j.1468-3083.2010.03925.x","article-title":"Use of intravenous immunoglobulin therapy during pregnancy in patients with pemphigus vulgaris","volume":"25","author":"Ahmed","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.intimp.2015.02.038_bb0045","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/cei.1996.104.s1.3","article-title":"Mechanisms of action of intravenous immune globulin in immune-mediated diseases","volume":"104","author":"Mouthon","year":"1996","journal-title":"Clin Exp Immunol"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576915000946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576915000946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T20:22:33Z","timestamp":1566418953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576915000946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S1567576915000946"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2015.02.038","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Positive clinical outcome with IVIg as monotherapy in recurrent pemphigoid gestationis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2015.02.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}